The ability of MANF to specifically enhance the proliferation of adult mouse β-cells10 suggests that it could be used as a therapeutic agent either in the preclinical stage or after the diagnosis of diabetes to promote the survival and proliferation of remaining β-cells in humans. This evidence concerns the gene MANF and diabetes mellitus.